VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 09/03/2024 at 07:00, 1 year 5 months ago

Valneva et Pfizer annoncent de nouvelles données positives de Phase 2 après une vaccination de rappel pour le candidat vaccin contre la maladie de Lyme
Valneva et Pfizer rapportent des données positives de Phase 2 pour le candidat vaccin contre la maladie de Lyme, montrant une forte réponse immunitaire post-vaccination de rappel

Valneva Phase 2 Maladie De Lyme Pfizer Vaccin
PRESS RELEASE

published on 09/03/2024 at 07:00, 1 year 5 months ago

Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate
Valneva and Pfizer announce positive Phase 2 booster results for Lyme disease vaccine candidate, VLA15-221, showing strong immune response and safety profile, advancing towards Phase 3 trials

Valneva Phase 2 Lyme Disease Vaccine Pfizer Immunogenicity
BRIEF

published on 08/30/2024 at 11:06, 1 year 5 months ago

Franchissement de seuil pour Valneva SE

Droits De Vote Franchissement De Seuil Marché Des Actions Valneva SE Groupe Grimaud
BRIEF

published on 08/30/2024 at 11:06, 1 year 5 months ago

Valneva SE Crosses Threshold

Voting Rights Stock Market Valneva SE Threshold Crossing Grimaud Group
PRESS RELEASE

published on 08/30/2024 at 11:01, 1 year 5 months ago

Franchissement de seuil
Déclaration de franchissement de seuil par Groupe Grimaud La Corbière pour VALNEVA SE

Déclaration Franchissement De Seuil AMF Valneva SE Groupe Grimaud La Corbière
PRESS RELEASE

published on 08/22/2024 at 10:51, 1 year 5 months ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH hat ein Research Update zu Valneva SE veröffentlicht. Analyst Simon Scholes behält seine Kaufempfehlung bei und bestätigt das Kursziel von EUR 8,60

First Berlin Equity Research Research Update Kaufempfehlung Aktienanalyse Valneva
BRIEF

published on 08/20/2024 at 16:06, 1 year 5 months ago

First Berlin Equity Research Reiterates Buy Rating for Valneva SE

Valneva Equity Research Market Undervaluation H1 Results Lyme Vaccine
BRIEF

published on 08/20/2024 at 16:06, 1 year 5 months ago

First Berlin Equity Research réitère sa recommandation d'achat pour Valneva SE

Valneva Recherche Sur Les Actions Vaccin Contre La Maladie De Lyme Sous-évaluation Du Marché Résultats H1
PRESS RELEASE

published on 08/20/2024 at 16:01, 1 year 5 months ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates research on Valneva SE (ISIN: FR0004056851) with a BUY recommendation and EUR 8.60 price target. H1 product sales slightly below consensus but gross margin improving. Valneva maintains full-year guidance

First Berlin Equity Research Buy Recommendation Valneva SE EUR 8.60 Price Target H1 Product Sales
BRIEF

published on 08/13/2024 at 07:05, 1 year 5 months ago

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates

Financial Results Cash Position Revenue Guidance Valneva Vaccine Development

Accesswire

Published on 02/07/2026 at 01:00, 23 hours 47 minutes ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 1 hour ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 2 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 9 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 11 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 3 hours 46 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 8 hours 11 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 8 hours 26 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 5 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 6 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 6 hours ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 6 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 8 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 8 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day 16 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE